Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03444480Phase 1Completed
Phase 1, randomised, double-blind trial in Anesthesia comparing Remimazolam + Flumazenil with Remimazolam + Placebo (2 arms). Primary endpoints: Peak Plasma Concentration of Remimazolam, Area under the plasma concentration versus time curve of Remimazolam and 2 more. Started Jul 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03444480.